i2b2 tranSMART Chairman of the Board
Congratulations to Zak on the recent publication of The AI REVOLUTION in MEDICINE: GPT-4 AND BEYOND and added title of Editor-In-Chief of a new journal from the New England Journal of Medicine entitled NEJM AI
Isaac Kohane, MD Ph D
Chair of the Department of Biomedical Informatics, Harvard Medical School
Marion V. Nelson Professor of Biomedical Informatics, Harvard Medical School
Associate Professor of Medicine, Brigham and Women’s Hospital
With generous support from
i2b2 Global South Network
This consortium consists of health-care institutions in limited-resource settings that are leveraging the i2b2 platform for facilitating the use of EHR data for clinical research, hospital operations and education. Currently the consortium includes sites from India and Nepal and is seeking to expand to other regions. This collaboration is to developed a resilient and cost-effective software stack suited for deployment in the low-resource setting.
From The Executive Director’s Desk
Happy New Year to our i2b2 tranSMART Community!
Board of Directors update:
We rely on our Board members for guidance and to set the overall strategic direction. Our members are a very diverse group of leaders from Academic Medical centers across the US and Europe as well as industry leaders.
Full list of Board members: Click HERE
Grant to the Foundation from Dell Technologies: Year 4
We are thrilled to announce our continued collaboration with Dell Technologies in supporting the development of the groundbreaking Personalized Digital Medical Twin. This transformative initiative involves the curation of real-world healthcare data, meticulously filtered to mirror a patient’s authentic condition through explainable AI.
Key Highlights:
- Explainable AI Integration: The Personalized Digital Medical Twin leverages cutting-edge explainable AI technology to ensure transparency and accuracy in reflecting a patient’s true health condition. This approach enhances the reliability and precision of the medical twin, setting new standards in personalized healthcare and supports finding a more accurate cohort for clinical trials.
- Computed Phenotypes in i2b2 v1.8.1: The latest release of i2b2, version 1.8.1, introduces advanced algorithms to calculate computed phenotypes. This innovative feature facilitates a deeper understanding of patient conditions, providing clinical investigators with invaluable insights to inform more precise cohort identification.
Symposium Invitation – Save the Date! We invite you to join us at our upcoming symposium on June 24-25 in Boston,
We are delighted to announce that our highly anticipated 2024 Symposium is set to take place on June 24-25 in the vibrant city of Boston. This event promises to be a hub of knowledge and innovation, showcasing the latest advancements in healthcare technology and research.
Agenda Highlights:
- Computed Phenotypes: Gain in-depth insights into the world of computed phenotypes and their transformative impact on personalized healthcare. Explore how these advanced algorithms are shaping the future of cohort identification.
- Digital Twin Initiative: Discover the intricacies of our Digital Twin initiative, a groundbreaking endeavor that harnesses the power of technology to create personalized representations of patients. Learn how this initiative will revolutionize clinical research.
- AI Chat-GPT i2b2 Prototypes: Experience firsthand the capabilities of our AI Chat-GPT i2b2 prototypes. Witness the potential of conversational AI in enhancing user interactions and extracting valuable insights from healthcare data.
- Use Cases: Explore real-world use cases that highlight the practical applications of our technologies. Gain a deeper understanding of how these innovations are making a tangible impact on clinical informatics.
- Working Group Updates: Stay informed with updates from our working groups, providing valuable insights into ongoing collaborations, research endeavors, and the collective efforts driving progress within the i2b2 community.
- New Releases and Development Roadmaps: Be the first to learn about our latest releases and the exciting roadmap for future developments. Discover how our commitment to innovation continues to shape the landscape of research informatics.
Check out our new i2b2 v1.8 release and stay tuned for v1.8.1
We are excited to introduce our latest i2b2 release, version 1.8.0, featuring a brand-new, modern, and user-friendly interface. This update represents a significant leap forward in enhancing the overall user experience, making i2b2 more accessible and intuitive for all users.
Key Highlights of i2b2 v1.8.0:
- Modern User Interface: Experience the convenience of a newly developed user interface that is not only aesthetically pleasing but also easy to operate. Our commitment to user-centric design ensures a seamless and efficient navigation experience.
- OMOP Data Model Compatibility: We are pleased to announce that i2b2 v1.8.0 is now fully compatible with the OMOP data model. This integration extends accessibility to users within the OHDSI community, providing them with the benefits of our user-friendly interface and robust functionalities.
Upcoming Release – i2b2 v1.8.1: Stay tuned for our upcoming release, i2b2 v1.8.1, scheduled for May. This release promises to deliver additional exciting features and enhancements, further elevating the capabilities of the i2b2 platform.
Anticipated Features in i2b2 v1.8.1:
- EnACT Network Rollout: i2b2 v1.8.1 is slated for rollout to the EnACT network, ensuring widespread accessibility and utilization of the latest advancements in the i2b2 platform.
- Loyalty Cohorts: Explore the introduction of Loyalty cohorts, enhancing cohort development and management capabilities.
- Data Quality Features: Benefit from new data quality features designed to elevate the accuracy and reliability of your data.
- Bulk Exporter: Experience the convenience of a bulk exporter, streamlining the process of exporting data for enhanced analysis and reporting.
We are committed to providing our users with cutting-edge tools that empower advancements in healthcare research. Your continued support and feedback are invaluable as we work towards delivering innovative solutions that meet and exceed your expectations.
I would love to hear from you!
If you have thoughts, comments, or want to get involved please send me an email. Click HERE
You must be logged in to post a comment.